Diastolic Cardiac Function Improvement by Liraglutide Is Mainly Body Weight Reduction Dependent but Independently Contributes to B-Type Natriuretic Peptide Reduction in Patients with Type 2 Diabetes with Preserved Ejection Fraction
利拉鲁肽改善舒张性心脏功能主要依赖于体重减轻,但其本身也能降低射血分数保留的2型糖尿病患者的B型钠尿肽水平。
期刊:Journal of Diabetes Research
影响因子:3.4
doi:10.1155/2021/8838026
Yagi, Kunimasa; Imamura, Teruhiko; Tada, Hayato; Chujo, Daisuke; Liu, Jianhui; Shima, Yuuki; Ohbatake, Azusa; Miyamoto, Yukiko; Okazaki, Satoko; Ito, Naoko; Nakano, Kaoru; Shikata, Masataka; Enkaku, Asako; Takikawa, Akiko; Honoki, Hisae; Fujisaka, Shiho; Origasa, Hideki; Tobe, Kazuyuki